Clinical trials: Primary CNS Lymphoma (PCNSL)
Primary CNS Lymphoma (PCNSL)
NB02 (Poseltinib) Combined Rituximab and Lenalidomide in R/R PCNSL
An Open, Single treatment arm, Multi-center, Prospective, Phase 2 Trial to Evaluate Efficacy and Safety of NB02 (Poseltinib) combined with Rituximab and Lenalidomide as a Salvage Therapy for Patients with Relapsed or Refractory…
- Trial name
- POTENTIAL-P (NCT06737250)
- Testing
- R2P -> RP
- Where
- 10 sites in South Korea
- Volunteers
- 33 people
- Sponsor
- NOBO Medicine